Evidence map›Paper›PMID 35884202›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Investigating the Antituberculosis Activity of Selected Commercial Essential Oils and Identification of Active Constituents Using a Biochemometrics Approach and In Silico Modeling.

Katyna J Boussamba-Digombou, Maxleene Sandasi, Guy P Kamatou, Sandy van Vuuren, Rafal Sawicki, Zeynab Fakhar, Alvaro M Viljoen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Katyna J Boussamba-DigombouDepartment of Pharmaceutical Sciences, Faculty of Science, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa.
Maxleene SandasiDepartment of Pharmaceutical Sciences, Faculty of Science, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa.
Guy P KamatouDepartment of Pharmaceutical Sciences, Faculty of Science, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa.ORCID 0000-0001-5518-9611
Sandy van VuurenDepartment of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown 2193, Johannesburg 2193, South Africa.ORCID 0000-0002-4859-1845
Rafal SawickiDepartment of Biochemistry and Biotechnology, Faculty of Pharmacy, Medical University of Lublin, Aleje Racławickie 1, 20-059 Lublin, Poland.ORCID 0000-0002-6593-8484
Zeynab FakharDepartment of Pharmaceutical Sciences, Faculty of Science, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa.
Alvaro M ViljoenDepartment of Pharmaceutical Sciences, Faculty of Science, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa.ORCID 0000-0002-6810-2981
Tshwane University of Technology · ZASouth African Medical Research Council · ZAMedical University of Lublin · PLUniversity of the Witwatersrand · ZA

Funding

National Research Foundation 86923South African Medical Research Council 23015
6 · The paper itself

Abstract

Tuberculosis (TB) is a disease caused by

Indexed as

antimycobacterialbiochemometricsessential oilsgas chromatography mass spectrometryminimum inhibitory concentrationmolecular dockingtuberculosis

Identifiers

PMID35884202
PMCPMC9311982
OpenAlexW4285596463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.